Tasha Elswick, PA
Physician Assistant · Winfield, WVNPI 1356307243
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 914 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,845 and has fallen 91.8% since, to $317 in 2025. Among physician assistant clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 914 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- AbbVie$2K
- Amgen$1K
- Lilly USA, LLC$877
- Boehringer Ingelheim$742
- plus $6K from 38 others
What the payments were for
- Food & beverage$14,490100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,490 in reported general payments places this provider in the 95th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 51 | $77,735 |
| OzempicSemaglutide | 25 | $53,979 |
| EliquisApixaban | 33 | $53,209 |
| Repatha SureclickEvolocumab | 37 | $47,596 |
| FarxigaDapagliflozin Propanediol | 28 | $43,368 |
| XareltoRivaroxaban | 27 | $38,583 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $28,988 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $26,597 |
| JanuviaSitagliptin Phosphate | 13 | $21,704 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $18,276 |
| MyrbetriqMirabegron | 12 | $15,864 |
| EntrestoSacubitril/Valsartan | 14 | $15,667 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,156 |
| BelsomraSuvorexant | 12 | $5,015 |
| SynthroidLevothyroxine Sodium | 30 | $4,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $742 | $77,73551 claims |
| Novo NordiskOzempic | $1,949 | $53,97925 claims |
| PfizerEliquis | $450 | $53,20933 claims |
| AstraZenecaFarxiga | $1,592 | $43,36828 claims |
| Johnson & JohnsonXarelto | $343 | $38,58327 claims |
| GSKTrelegy Ellipta | $666 | $28,98822 claims |
| MerckJanuvia, Belsomra | $221 | $26,71925 claims |
| Astellas Pharma US IncMyrbetriq | $309 | $15,86412 claims |
| NovartisEntresto | $216 | $15,66714 claims |
| AbbVieSynthroid | $1,566 | $4,01530 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $31 | $1,415126 claims |
| Almatica Pharma LLCSertraline Hcl | $64 | $55253 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Winfield
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
- Jason TrustyCharleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.